These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11715823)

  • 1. Argatroban.
    Am J Health Syst Pharm; 2001 Nov; 58(21):2027-9. PubMed ID: 11715823
    [No Abstract]   [Full Text] [Related]  

  • 2. Argatroban and Bivalirudin for Perioperative Anticoagulation in Cardiac Surgery.
    Koster A; Faraoni D; Levy JH
    Anesthesiology; 2018 Feb; 128(2):390-400. PubMed ID: 29206646
    [No Abstract]   [Full Text] [Related]  

  • 3. A synopsis of the clinical uses of argatroban.
    Moledina M; Chakir M; Gandhi PJ
    J Thromb Thrombolysis; 2001 Oct; 12(2):141-9. PubMed ID: 11729365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Argatroban use in dialysis patients.
    Reddy BV
    Semin Dial; 2004; 17(1):73. PubMed ID: 14717821
    [No Abstract]   [Full Text] [Related]  

  • 5. Heparin-induced thrombocytopenia with aortoiliac thrombosis treated with argatroban.
    Alarcón Pérez L; Rodríguez Huerta AM; Duque González P
    Med Clin (Barc); 2017 Mar; 148(6):286-287. PubMed ID: 28131516
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibitory effect of argatroban on thrombin-antithrombin III complex after percutaneous transluminal coronary angioplasty.
    Sakamoto S; Hirase T; Suzuki S; Tsukamoto T; Miki T; Yamada T; Matsuo T
    Thromb Haemost; 1995 Aug; 74(2):801-2. PubMed ID: 8585029
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of intraoperative free flap arterial thrombosis with argatroban in the heparin-allergic patient.
    Shuck J; Endara M; Davison SP
    Plast Reconstr Surg; 2014 Oct; 134(4):672e. PubMed ID: 25357073
    [No Abstract]   [Full Text] [Related]  

  • 8. Argatroban: a synthetic thrombin inhibitor of low relative molecular mass.
    Fitzgerald D; Murphy N
    Coron Artery Dis; 1996 Jun; 7(6):455-8. PubMed ID: 8889361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preventive effects of synthetic antithrombin, MD-805, on animal thrombosis models].
    Iwamoto M; Kumada T; Hara T; Abiko Y; Ogawa H; Tomikawa M
    Rinsho Byori; 1987 Sep; Spec No 73():142-9. PubMed ID: 3437529
    [No Abstract]   [Full Text] [Related]  

  • 10. Argatroban therapy using enzymatic anti-factor IIa monitoring.
    Shepherd MF; Jacobsen JM; Rosborough TK
    Ann Pharmacother; 2011 Mar; 45(3):422-3. PubMed ID: 21386028
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative antithrombotic effects of heparin, recombinant hirudin and argatroban in a hamster femoral vein platelet-rich mural thrombosis model.
    Imura Y; Stassen JM; Collen D
    J Pharmacol Exp Ther; 1992 Jun; 261(3):895-8. PubMed ID: 1602394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Argatroban for Treatment of Heparin-Induced Thrombocytopenia and Thrombosis in a Patient with Multiple Myeloma Undergoing Hemodialysis.
    Giorgi-Pierfranceschi M; Mumoli N; Scarpioni R; Croci E; Dentali F
    J Am Geriatr Soc; 2016 Aug; 64(8):1748-50. PubMed ID: 27448437
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of argatroban on thrombus formation during acute coronary occlusion after balloon angioplasty.
    Suzuki S; Sakamoto S; Adachi K; Mizutani K; Koide M; Ohga N; Miki T; Matsuo T
    Thromb Res; 1995 Feb; 77(4):369-73. PubMed ID: 7740527
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment options for heparin-induced thrombocytopenia.
    Greinacher A
    Am J Health Syst Pharm; 2003 Oct; 60 Suppl 5():S12-8. PubMed ID: 14593978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of argatroban.
    Jeske WP; Fareed J; Hoppensteadt DA; Lewis B; Walenga JM
    Expert Rev Hematol; 2010 Oct; 3(5):527-39. PubMed ID: 21083469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argatroban approved for heparin-induced thrombocytopenia.
    Miller JL
    Am J Health Syst Pharm; 2000 Sep; 57(18):1650. PubMed ID: 11006790
    [No Abstract]   [Full Text] [Related]  

  • 17. Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
    Lewis BE; Matthai WH; Cohen M; Moses JW; Hursting MJ; Leya F;
    Catheter Cardiovasc Interv; 2002 Oct; 57(2):177-84. PubMed ID: 12357516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argatroban: for a few selected patients.
    Prescrire Int; 2013 Feb; 22(135):33-5. PubMed ID: 23444494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.
    Lewis BE; Walenga JM; Wallis DE
    Semin Thromb Hemost; 1997; 23(2):197-202. PubMed ID: 9200347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regional cerebral blood flow amelioration of argatroban in the acute stage of cerebral thrombosis.
    Yamashita T; Hayashida O; Nagamitsu T; Nagatsuna T; Wakuta Y; Fudaba H
    Keio J Med; 2000 Feb; 49 Suppl 1():A141-4. PubMed ID: 10750366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.